养五步蛇年入百万
Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial_蜘蛛资讯网

pain scores. This meticulous allocation enhanced the reliability of the clinical outcomes. A notable aspect of the study design was the inclusion of two primary efficacy endpoints. These simultaneousl
ficant improvements were seen in all key indicators, including the Visual Analog Scale (VAS) (p-value CARTISTEM also exhibited an excellent safety profile, with all serious adverse events (SAEs) durin
当前文章:http://z7o7s5t.mushenlu.cn/p0tgjf/zuvhk6.html
发布时间:00:00:00
















